Cepheid, Medline distribution agreement, 6/16

Create PDF

June 2016—Cepheid announced an agreement with Medline for the distribution of the Gene­Xpert System and menu of Xpert tests, which includes health care associated infections, critical infectious disease, and sexual health. Under the terms of the nonexclusive agreement, Medline will begin offering the GeneXpert system to non-acute care laboratory customers in the United States, including long-term care facilities with moderately complex labs, physician-office laboratories, women’s health and large multispecialty clinics, urgent care facilities, community health centers, correctional facility laboratories, student health centers, STD clinics, and reference laboratories.

The distribution agreement will focus initially on the GeneXpert system and Xpert tests and the CLIA-waived version of Cepheid’s Flu and RSV test. Subject to FDA review of the GeneXpert Omni System and associated tests, Medline will also distribute Cepheid’s CLIA-waived products for the GeneXpert Omni.

Cepheid, 408-541-4191